Task: Answer the MCQ question.
Query: Which compound exhibits a -0.531\% human ether-à-go-go related gene (hERG) inhibition at a concentration of 1uM?
Constraint: You must select none, one or more options from a, b, or c without using any other words.
Options:
a. Cc1[nH]c2ccccc2c1C(=O)COc1ccccc1
b. CCOc1cc(C2C3=C(CC(C)(C)CC3=O)N(C)C3=C2C(=O)CC(C)(C)C3)ccc1O
c. COc1ccc2nc(N3C(=O)/C(=C/c4ccccc4)NC3=S)sc2c1
Answer: c. COc1ccc2nc(N3C(=O)/C(=C/c4ccccc4)NC3=S)sc2c1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_1uM#}{herg_central_at_1uM__units} {herg_central_at_1uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_1uM%}
Answer: {%multiple_choice_result}. {SMILES#}
COc1ccc2nc(N3C(=O)/C(=C/c4ccccc4)NC3=S)sc2c1
COc1ccc2nc(N3C(=O)/C(=C/c4ccccc4)NC3=S)sc2c1
(5Z)-5-benzylidene-3-(6-methoxy-1,3-benzothiazol-2-yl)-2-sulfanylideneimidazolidin-4-one